| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.005 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |